Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03593031 · ClinicalTrials.gov registry record · NA
Neural Mechanism of Vision Therapy for Patients With Convergence Insufficiency
A NA study of Convergence Insufficiency, sponsored by New Jersey Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03593031: Completed NA study of Convergence Insufficiency, sponsored by New Jersey Institute of Technology.
NCT03593031 is a NA study of Convergence Insufficiency that has completed, run by New Jersey Institute of Technology. The registered enrollment target is 100 participants, roughly in line with the 109-participant average among 6 other Convergence Insufficiency trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03593031, a NA study of Convergence Insufficiency, has completed, sponsored by New Jersey Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Convergence insufficiency (CI) is a prevalent binocular vision disorder with symptoms that include double/blurred vision, eyestrain, and headaches when engaged in reading or other near work. CI is present in 4% of the population where approximately 27% of CI patients do not improve even with validated therapy. The project will quantitatively study changes in convergence eye movements and neural substrates before and after validated therapy in CI patients. This knowledge can lead to improvements in currently validated therapy, reduction in therapy sessions, and reduced healthcare costs.
Primary Outcome
how accurate a patient can fixate on a new target
Conditions Studied
Interventions
- BEHAVIORAL Office Based Vergence and Accommodative Therapy
Study Locations (1)
New Jersey
- NJIT - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2020-01-01 |
| Phase | NA |
What the finished NCT03593031 record still lists
NCT03593031 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 109-participant average among 6 other Convergence Insufficiency trials with a reported enrollment target.
The record links to 1 condition, with Convergence Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Office Based Vergence and Accommodative Therapy is the first listed.
NCT03593031 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03593031 about?
NCT03593031 is a clinical study titled "Neural Mechanism of Vision Therapy for Patients With Convergence Insufficiency". Convergence insufficiency (CI) is a prevalent binocular vision disorder with symptoms that include double/blurred vision, eyestrain, and headaches when engaged in reading or other near work. CI is present in 4% of the population where approximately 27% of CI patients do not improve even with validat...
What is the current status of trial NCT03593031?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-04-01. Estimated completion is 2020-01-01.
What conditions does trial NCT03593031 study?
This clinical trial studies the following conditions: Convergence Insufficiency.
What interventions are being tested in trial NCT03593031?
The interventions under investigation include: Office Based Vergence and Accommodative Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03593031?
This trial is sponsored by New Jersey Institute of Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03593031 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Convergence Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
RECRUITING · NA
-
Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency
RECRUITING · NA
-
Home-based Vision Therapy
RECRUITING · Phase 1
-
Effectiveness of Virtual Reality Vision Therapy - VERVE
RECRUITING · Early Phase 1
-
A Prospective Observational Study of Adult Strabismus
COMPLETED
-
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI